May 22, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Care Capital Properties Inc (NYSE:CCP), was announced concerning whether the takeover of Care Capital Properties Inc by Sabra Health Care REIT, Inc for a value of approximately $29.96 per share is unfair to NYSE:CCP stockholders.

The investigation by a law firm concerns whether certain officers and directors of Care Capital Properties Inc breached their fiduciary duties owed to NYSE:CCP investors in connection with the proposed acquisition.

On May 7, 2017, Sabra Health Care REIT, Inc. and Care Capital Properties, Inc. (NYSE:CCP) announced that they have entered into an agreement pursuant to which the two companies will combine in an all-stock merger to create a premier healthcare REIT. Under the terms of the agreement, CCP shareholders will receive 1.123 shares of Sabra common stock for each share of CCP common stock they own. Based on a closing price of $26.68 per NASDAQ:SBRA shares investors in Care Capital Properties Inc (NYSE:CCP) will receive a value of approximately $29.96 per NYSE:CCP share.

However, given that at least one analyst has set the high target price for NYSE:CCP shares at $32.00 per share, the investigation concerns whether the offer is unfair to NYSE:CCP stockholders. More specifically, the investigation concerns whether the Care Capital Properties Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.